The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth. The agency approved Sage Therapeutics’ Zulresso, an IV drug given over 2 ½ days.
The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth. The agency approved Sage Therapeutics’ Zulresso, an IV drug given over 2 ½ days.